How to Help Your Patients Find Humalog in Stock: A Provider's Guide

For patients with Type 1 diabetes, running out of rapid-acting insulin isn't an inconvenience — it's a medical emergency. When a patient calls your office saying they can't fill their Humalog prescription, a fast, coordinated response can prevent a serious adverse event.

This guide is written for endocrinologists, PCPs, internists, and NPs who care for patients on Humalog. It covers the tools, protocols, and scripts your team can use to help patients locate Humalog — or an appropriate alternative — quickly and efficiently.

Step 1: Understand Why the Patient Can't Fill the Prescription

When a patient reports difficulty filling Humalog, the root cause matters for determining the right solution. The four most common reasons:

• Pharmacy stock shortage: The specific pharmacy is out of Humalog (but other pharmacies likely have it). Solution: help patient find a pharmacy with stock.
• Discontinued product form: The prescription is written for 3 mL Humalog vials, which were permanently discontinued in 2024. Solution: update the prescription to 10 mL vials or KwikPens.
• Insurance/formulary issue: The patient's plan doesn't cover Humalog or requires prior authorization. Solution: submit prior auth or switch to a covered alternative.
• Cost barrier: The patient can't afford their copay or out-of-pocket cost. Solution: direct to the Lilly Insulin Value Program ($35/month cap) or Lilly Cares Foundation (free insulin).

Step 2: Update Outdated Prescriptions

If your practice still has active prescriptions for Humalog or insulin lispro 3 mL vials on file, take time to update them proactively. The 3 mL vials were permanently discontinued by Eli Lilly in 2024. These prescriptions will result in automatic fill failures at the pharmacy.

Recommended update:

• Humalog or insulin lispro injection 100 units/mL, 10 mL vial — or —
• Humalog KwikPen 100 units/mL, 3 mL cartridge (5 pens per box)

Step 3: Help Patients Locate Stock — The Fast Way

Pharmacy locating is time-consuming for patients — especially those who are elderly, have limited mobility, or don't have the cognitive bandwidth to manage a shortage on top of their illness. medfinder is a service that calls pharmacies on behalf of patients to find which ones have Humalog in stock and can fill the prescription. Patients provide their medication, dosage, and location — medfinder does the calling — and results are texted back.

Consider adding medfinder.com to your patient handouts for shortage situations. It's a practical tool that can reduce both patient anxiety and after-hours calls to your office.

Step 4: Quickly Switch to an Available Alternative Insulin

If your patient can't find Humalog anywhere nearby and needs insulin today, switching to an available rapid-acting alternative is clinically appropriate and safe. Here's a quick reference for your team:

• Admelog (insulin lispro, Sanofi) — 1:1 conversion; same molecule; requires new prescription; available as vials + SoloStar pens
• NovoLog (insulin aspart, Novo Nordisk) — 1:1 conversion; FlexTouch pen available; vials and FlexPen discontinued Dec 2025
• Apidra (insulin glulisine, Sanofi) — 1:1 conversion; vials and SoloStar pens available; approved for age 4+
• Fiasp (ultra-rapid insulin aspart, Novo Nordisk) — 1:1 conversion; faster onset requires meal timing adjustment; adults and children ≥2

Step 5: Address Cost Barriers Proactively

Cost remains a barrier for many patients — even at today's lower prices. Build a practice workflow for identifying cost barriers:

• Lilly Insulin Value Program: Caps Humalog and generic insulin lispro at $35/month for insured and uninsured patients. Savings card at insulinaffordability.com.
• Lilly Cares Foundation: Free insulin for qualifying uninsured patients at ≤400% FPL. LillyCares.com, 1-800-545-6962.
• Medicare Part D: $35/month insulin cap under the Inflation Reduction Act for all Medicare beneficiaries.
• Authorized generic insulin lispro: Same as Humalog; $25 list price per 10 mL vial. Consider writing for the generic by name.

Emergency Protocol: Patient Is Out of Insulin Today

If a patient with Type 1 diabetes contacts your office saying they have no insulin and cannot find Humalog:

1. Immediately call or e-prescribe an alternative rapid-acting insulin (Admelog or NovoLog) to the nearest pharmacy that has stock.
2. If no rapid-acting analogs are available, consider a short-term bridge with regular human insulin (Humulin R or Novolin R, available OTC) with explicit dosing and timing instructions.
3. Schedule urgent follow-up to monitor blood glucose and titrate as needed.
4. Document the shortage reason in the patient's chart for insurance/prior auth purposes.

For a broader clinical overview of the shortage and formulary landscape, see our guide on what providers need to know about the Humalog shortage in 2026.